NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul A. MahonEVP GENERAL COUNSEL2026-01-022,181$487.76
$1.06MSell
Paul A. MahonEVP GENERAL COUNSEL2026-01-02200$489.15
$97.83kSell
Paul A. MahonEVP GENERAL COUNSEL2026-01-028,300$146.03
$1.21MBuy
Paul A. MahonEVP GENERAL COUNSEL2026-01-02822$481.26
$395.60kSell
Paul A. MahonEVP GENERAL COUNSEL2026-01-02479$481.83
$230.80kSell
Paul A. MahonEVP GENERAL COUNSEL2026-01-02739$483.35
$357.19kSell
Paul A. MahonEVP GENERAL COUNSEL2026-01-021,240$484.54
$600.82kSell
Paul A. MahonEVP GENERAL COUNSEL2026-01-021,509$485.68
$732.89kSell
Paul A. MahonEVP GENERAL COUNSEL2026-01-021,130$486.85
$550.14kSell
Michael BenkowitzPRESIDENT AND COO2025-12-2914,625$117.76
$1.72MSell

1 of 95

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.43%5,352,996$2.66BInstitution
Lilly Co Eli12.20%5,251,394$2.61BInsider
Vanguard Group Inc10.26%4,418,610$2.19BInstitution
Renaissance Technologies LLC5.05%2,173,392$1.08BInstitution
Avoro Capital Advisors LLC4.70%2,022,222$1.00BInstitution
State Street Corp4.47%1,922,609$955.00MInstitution
Wellington Management Group LLP3.25%1,398,781$694.80MInstitution
Geode Capital Management LLC2.90%1,249,660$620.73MInstitution
Aqr Capital Management LLC2.29%986,478$490.00MInstitution
Martine A. Rothblatt1.95%838,072$416.29MInsider

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR86.71%13.29%Net SellingNet Selling
GMAB96.17%0.00%
RPRX56.76%17.33%Net SellingNet Selling
INCY77.70%22.30%Net SellingNet Selling
BNTX20.98%0.00%

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 94.94% institutional shareholders, 14.55% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 12.20% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $2.61B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.